Recent research has highlighted the genetic aspects of amyotrophic lateral sclerosis (ALS), focusing on the GGGGCC repeat expansion in the C9orf72 gene. This genetic mutation is a significant cause of ALS and is being studied to understand its impact on the nervous system.
Studying these mutations in model organisms aims to uncover the underlying mechanisms of ALS and develop more effective treatments. This research contributes to ongoing efforts to understand and combat ALS, a condition with complex causes (Wei et al., 2025).
Clinical Trials
This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: